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Association Between High Myopia and
Progression of Visual Field Loss in 
Primary Open-angle Glaucoma
Yi-An Lee, Yung-Feng Shih, Luke Long-Kuang Lin, Jehn-Yu Huang, Tsing-Hong Wang*
Background/Purpose: Taiwan has a very high prevalence rate of myopia. We retrospectively studied the
influence of myopia on the progression of visual field (VF) loss in primary open-angle glaucoma (POAG)
patients.
Methods: We studied 515 POAG patients for a minimum follow-up period of 5 years. VF examination was
performed with Humphrey perimeter, 30-2 SITA standard program, every 6 months. A point-wise numer-
ical comparison was applied to judge the VF changes. Test points showing more than 1.0 dB of sensitivity
loss in mean defect were identified. A location was considered to have progression if it was detected on
two consecutive visits. Progression of VF loss was confirmed if three or more test points deteriorated.
Multivariate logistic regression was used to evaluate the association between progression of VF loss and
various risk factors.
Results: There were 262 cases. Progression of VF loss occurred in 57 eyes (21.8%) during the 5-year follow-
up period. Logistic regression revealed that the deterioration was associated with older age, higher mean
intraocular pressure, larger vertical cup-to-disc ratio, and greater myopic refraction status. The incidence 
of VF loss progression was 15.1% in the group of eyes with myopia less than −3 D, 10.5% in the group
with −3 D to −6 D, 34.4% in the group with −6 D to −9 D, and 38.9% in the group with myopia greater
than −9 D.
Conclusion: POAG patients with myopia greater than −6 D had a greater progression of VF loss. [J Formos
Med Assoc 2008;107(12):952–957]
Key Words: glaucoma, myopia, visual field
Glaucoma affects more than 66 million people
worldwide, and at least 6.8 million individuals
have bilateral blindness.1 Primary open-angle glau-
coma (POAG) is the most common type of glau-
coma.2 It is a slow progressive degeneration of
retinal ganglion cells and results in a characteristic
appearance of the optic disc and concomitant 
visual field (VF) loss. Without adequate and timely
treatment, patients with POAG are threatened with
visual disability and possible blindness. A better
understanding of the risk factors that contribute
to disease progression would be helpful in the
management and prevention of further degener-
ation of retinal ganglion cells.
Glaucomatous VF defects may continue to
progress despite good control of intraocular pres-
sure (IOP). Over the past few decades, various
studies have identified many risk factors for the
incidence and prevalence of glaucoma, but few risk
factors that contribute to deterioration of glaucoma
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damage have been reported. These risk factors in-
clude increased IOP, diurnal IOP variation,3,4 disc
crescent,5 and disc hemorrhage.6,7 There is still a
lack of evidence to link other reported risk factors
with progression of glaucoma, such as myopia.
Myopia has reached epidemic proportions
and is already a serious public health problem in
certain parts of the world,8 including Taiwan.9
Myopic eyes may be more susceptible to glauco-
matous damage at certain levels of IOP for the
following reasons. The myopic scleral canal is
unusually large, abnormally shaped and tilted,10
and the myopic lamina cribrosa and peripapillary
sclera are unusually thin.11,12 This may intensify
the stress for a given level of IOP.12 However, the
clinical results are not conclusive. Mitchell et al
reported increased risk of ocular hypertension in
the low myopic group (myopia <−3 D) in the Blue
Mountains Eye Study,13 but they did not find any
difference between low and moderate-to-high
myopia groups. In the Ocular Hypertension
Treatment Study, Kass et al did not show that
myopia > −1 D was a significant risk for the onset
of glaucomatous damage.14 In their study of an-
isometropia, Jonas et al found no considerable
difference in neuroretinal rim area and mean VF
defect between the eyes, and suggested that for
eyes with myopia < −8 D, refractive error did not
contribute much to optic nerve head susceptibil-
ity to certain IOP levels.15 However, Chihara and
associates made a different observation. They
found that moderate-to-severe myopia (> −4 D),
but not mild myopia, was a significant risk factor
for the progression of VF loss in glaucoma.16 In
the present study, we tried to elucidate the rela-
tionship between myopia and the progression of
VF loss in POAG patients.
Methods
Patients and examinations
After being approved by the Institutional Review
Board for Human Research of the National
Taiwan University Hospital, we reviewed the
medical records of 515 POAG patients who had
been regularly followed-up every 3 months at the
glaucoma clinic of National Taiwan University
Hospital from January 1995 to December 2005.
Minimum follow-up period was 5 years. Ophthal-
mic examinations included best corrected visual
acuity, slit lamp biomicroscopy, evaluation of
IOP (Goldmann applanation tonometer), mea-
surement of central corneal thickness (CCT)
using ultrasonic pachymetry (Micropach 200P +;
Sonomed, Lake Success, NY, USA), and ocular
biometry using A-scan ultrasonography (A-1500;
Sonomed). Cycloplegic refractive status was deter-
mined by an autorefractometer (RK-3000; Topcon,
Tokyo, Japan) and stereophotographs were ob-
tained (Topcon TRC-SS2). Spherical equivalent
refractive error was calculated as: (sphere + 1/2
cylinder), and expressed in diopters (D) for analy-
sis. VF examination (30-2 SITA standard, Visual
Field Analyzer Model 745i; Allergan-Humphrey,
San Leandro, CA, USA) was performed on a 
6-monthly basis.
The exclusion criteria were: history of ocular
trauma or surgery; conditions that may produce
VF defects such as corneal opacity, retinopathy,
pupil diameter < 3 mm, and non-glaucomatous
optic neuropathy; best corrected visual acuity
worse than 20/30; and age < 15 or > 75 years. For
patients who had POAG in both eyes, the one
with milder VF defect was selected for analysis.
Diagnosis of POAG
Stereophotographs were examined. The optic
cup was defined on the basis of contour and not
of pallor. The border of the optic disc was identi-
cal with the inner side of the peripapillary scleral
ring. Cup-to-disc (C/D) ratios were computed
for vertical and horizontal meridians in each eye.
Glaucomatous changes of the optic nerve head
included thinning of the inferior or superior
neuroretinal rim, and localized or diffuse retinal
nerve fiber layer defects. The vertical C/D ratio
was used for analysis.
Characteristic glaucomatous VF loss was de-
fined as the following defects not explained by
other ocular or neurologic causes: (1) at least three
non-edge adjacent test points with a deviation
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deeper than 5 dB, and one must be deepened by
10 dB; and (2) at least two non-edge adjacent
points with a deviation deeper than 10 dB. The
points must be in a cluster in an expected loca-
tion. The rate of false-positive and false-negative
answers had to be ≤ 15%.
The diagnosis of POAG was made by a typical
glaucomatous optic neuropathy associated with
corresponding VF defects. The patient should have
an open and normal anterior chamber drainage
angle, and only glaucoma could have explained the
optic neuropathy and VF defects. Pre-perimetric
glaucoma patients were excluded from this study.
Definition of progression of VF loss
Three VFs were obtained in the first 6 months,
and the last two measurements were averaged as
the baseline. A point-wise numerical comparison
was applied to judge the serial VF examination
changes. Test points that showed ≥ 1.0 dB sensi-
tivity loss in mean defect were identified at each
follow-up visit. A point was considered to have
confirmed progression if it was detected in the
same point in two consecutive fields. The criteria
for VF progression were confirmed progression
in three or more test points.17 If VF only showed
progression the first time, and the next VF result
was back to baseline or better than baseline, the
first VF result was regarded as no progression
and discarded. If the patient’s visual acuity had
changed more than two lines between VF exami-
nations, the VF results were also abandoned.
Statistical analysis
We used multivariate logistic regression to evalu-
ate the association between progression of VF
loss and risk factors. Mean IOP was the average
of measurements taken on a 3-monthly basis.
Progression of VF loss and IOP (> 21 mmHg or
≤ 21 mmHg) during the follow-up period was the
two binary variables in the logistic regression. The
other variables were continuous variables. We di-
vided the patients into four groups by their refrac-
tion status: (1) myopia ≤−3 D; (2) myopia >−3 D,
but ≤ −6 D; (3) myopia > −6 D, but ≤ −9 D; and
(4) myopia > −9 D. We compared the incidence
of VF loss progression between groups. The soft-
ware package SAS version 9.0 (SAS Institute Inc.,
Cary, NC, USA) was used for statistical analysis.
Results
There were 262 cases, with a mean age of 48.6 ±
14.2 years (range, 16–75); 163 were male and 
99 were female. We selected 136 right eyes and
126 left eyes for data analysis. Patients were ex-
cluded because of irregular follow-up or VF 
examination schedule (172 cases), age > 75 years
(38 cases), and best corrected visual acuity worse
than 20/30 in the better eye (43 cases). The mean
follow-up period was 8.7 ± 2.2 years and the 
patients had 14.8 ± 3.6 VF tests.
Progression of VF loss occurred in 57 eyes
(21.8%) in the 5-year follow-up period. As com-
pared with the eyes without VF progression, the
eyes with VF progression were from older patients
(51.4 ± 12.3 years vs. 46.4 ± 14.2 years, p = 0.034);
had higher mean IOP (16.1±3.7 mmHg vs. 15.8±
2.8 mmHg, p = 0.015); had more eyes with IOP >
21 mmHg (24.6% vs. 11.7%, p=0.034); had higher
initial vertical C/D ratio (0.83 ± 0.14 vs. 0.73 ±
0.16, p < 0.001); had greater myopic refraction
status (−7.10±4.40 D vs. −4.55±4.00 D, p<0.001);
and had longer ocular axial length (26.49 ±
1.95 mm vs. 25.39±1.83 mm, p<0.001) (Table 1).
Their difference in CCT was not remarkable
(545.0 ± 29.1 μm vs. 549.2 ± 34.6 μm, p = 0.449).
We used logistic regression to evaluate the in-
fluence of these parameters on progression of VF
loss. The variables of logistic regression included
age, CCT, mean IOP, C/D ratio, and refraction
status. The results revealed that older age, higher
mean IOP, larger vertical C/D ratio, and greater
myopic refraction status were risk factors for pro-
gression of VF loss (Table 2). Thinner CCT was
not a significant risk factor for progression of VF
loss (p = 0.924).
Progression of VF loss between patients with
different refraction status is shown in Table 3.
Eyes with greater myopic refraction status showed
a higher progression rate than those with lower
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status. This phenomenon was more evident when
the refraction status was more myopic than −6 D.
Discussion
The present study revealed that IOP and greater
myopic refraction status were risk factors for pro-
gression of VF loss in POAG patients.
There is no consensus about the best method
to detect progression of VF loss. The ideal method
for analyzing VF changes should discover progres-
sion with a few examinations and be resistant to
fluctuation. Methods that yield a high number of
progressive cases are often less specific and are
influenced by fluctuation. In contrast, those meth-
ods that have high specificity often require very
long follow-up times. Point-wise linear regression
analysis (PLRA) generally has high specificity.17
The main drawback of this method is that it re-
quires a long time to detect progression. Another
issue of PLRA is that there is no accepted crite-
rion on either the number of test locations that
show significant decline in sensitivity, or the
magnitude of change (db/year) at each location.
However, this is also a common problem for
other methods.
Whether myopic eyes are more susceptible to
glaucomatous damage is still debatable, but in-
creasing evidence supports the suggestion that
highly myopic eyes are different in structure from
non-myopic or mildly myopic eyes, and may be a
risk factor for glaucomatous damage and progres-
sion of VF loss in POAG patients.18,19 Our previous
work using confocal laser scanning ophthalmo-
scopy has revealed that optic disc size is correlated
with ocular axial length only in high myopia pa-
tients (>−8.0D), but not in mildly myopic patients
(< −3 D).20 Jonas has also demonstrated a similar
finding.21 Other investigations have focused on
the mechanisms that may explain the increased
Table 1. Comparison of risk factors between eyes with and without progression of visual field (VF) loss*
With VF loss Without VF loss 
Total p
progression progression
Eyes 57 (21.8) 205 (78.2) 262 (100)
Age (yr) 51.4 ± 12.3 (24–74) 46.4 ± 14.2 (16–74) 48.6 ± 14.2 (16–74) 0.034
Central corneal thickness (μm) 545.0 ± 29.1 (488–630) 549.2 ± 34.6 (472–707) 548.3 ± 33.5 (472–707) 0.449
Mean IOP (mmHg) 16.1 ± 3.7 (10–26) 15.8 ± 2.8 (9–26) 15.9 ± 2.9 (9–26) 0.015
Eyes with IOP > 21 mmHg 14 (24.6) 24 (11.7) 38 (14.8) 0.02
Initial VF mean defect (dB) −5.59 ± 4.33 −5.03 ± 4.50 −5.10 ± 4.41 0.156
Vertical cup-to-disc ratio 0.83 ± 0.14 0.73 ± 0.16 0.75 ± 0.15 < 0.001
Refraction status (D) −7.1 ± 4.4 −4.55 ± 4.0 −5.1 ± 4.2 < 0.001
Ocular axial length (mm) 26.49 ± 1.95 25.39 ± 1.83 25.63 ± 1.90 < 0.001
*Data presented as n (%) or mean ± standard deviation (range) or mean ± standard deviation. IOP = intraocular pressure.
Table 2. Influence of age, central corneal thickness, mean
intraocular pressure, vertical cup-to-disc ratio, and
refraction status on progression of visual field loss*
OR (95% CI) p
Age 1.033 (1.002–1.064) 0.003
Central cornea thickness 0.999 (0.988–1.011) 0.924
Mean intraocular pressure 3.574 (1.393–9.029) 0.019
Cup-to-disc ratio 1.054 (1.023–1.086) < 0.001
Refraction status 4.686 (2.078–10.568) < 0.001
*As analyzed by logistic regression. OR = odds ratio; CI = confidence interval.
Table 3. Incidence of progression of visual field (VF) loss with
different myopic refraction status*
Refraction status




< −3 D 13 (15.1) 73 (84.9) 86 (100)
> −3 D, but ≤ −6 D 8 (10.5) 68 (89.5) 76 (100)
> −6 D, but ≤ −9 D 22 (34.4) 42 (65.6) 64 (100)
> −9 D 14 (38.9) 22 (61.1) 36 (100)
Total 57 (21.8) 205 (78.2) 262 (100)
*Data presented as n (%).
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susceptibility to glaucoma of highly myopic eyes.
In enucleated human eyes, Dichtl et al demon-
strated that the lamina cribrosa is significantly thin-
ner in highly myopic eyes.22 The thinner lamina
cribrosa may steepen the translaminar pressure
gradient at a given IOP, and contribute to vulner-
ability to glaucoma progression in myopic eyes.12
Axial elongation in myopic eyes is associated with
scleral remodeling, which causes marked thinning
of the sclera, especially at the posterior pole.23
This scleral remodeling results in reduced glycos-
aminoglycan and collagen content, and scleral
resistance to expansion at a given level of IOP.24
Furthermore, it is postulated that reduced blood
flow in the ocular arteries correlates with neuro-
retinal rim damage and POAG progression.25,26
Since blood flow of myopic eyes decreases as my-
opic refraction status increases, progression of
POAG in highly myopic patients may also be
caused by decreased optic nerve head perfusion.27
We showed that age and initial vertical C/D
ratio were also risk factors for progression of VF
loss in POAG patients. In general, there is an in-
crease in IOP with age; thus, the prevalence of
POAG increases with aging. However, Shiose
found a significant decrease in IOP with age in
Japanese people,28 whereas a longitudinal analy-
sis has shown a different result.29 Optic nerve head
perfusion is also reduced in elderly people.30
However, these findings do not imply increased
vulnerability of aged axons to glaucoma damage.31
Our results demonstrated that higher mean
IOP and greater incidence of IOP > 21 mmHg were
both significantly associated with progression of
VF loss in POAG patients. It is still a controversial
issue as to whether mean IOP or fluctuation in
IOP is really important to glaucoma progression.
In the Early Manifest Glaucoma Trial, Bengtsson 
et al showed that mean IOP was correlated with
risk of progression.32 Nouri-Mahdavi et al reported
in the Advanced Glaucoma Intervention Study that
IOP fluctuation rather than mean IOP correlated
better with progression.3 Palmberg concluded that
in subjects with moderately severe damage, main-
taining IOP in the low-to-normal range can give
the optic nerve an optimal chance of stabilization.
Reducing the IOP by ≥ 35% may be a successful
strategy for glaucoma patients with mild disease
at diagnosis.33
We did not find that CCT was a risk factor for
progression of VF loss. The Ocular Hypertension
Treatment Study reported that the risk of develop-
ing POAG was inversely correlated with CCT,
when other potential determinants of glaucoma
risk were adjusted.34 Several other studies have
provided further evidence to support this find-
ing.35,36 However, some investigators have not
found any association between CCT and optic
nerve or progression of VF loss in patients with
existing glaucoma,37,38 and results from the Early
Manifest Glaucoma Trial39 and the Barbados Eye
Study40 were similar. Jonas et al found that highly
myopic cadaver eyes have thinner lamina cribrosa
than eyes without high myopia.11 However, CCT
was not found to be correlated with axial length41
or lamina cribrosa thickness in normal cadaver
eyes without glaucoma.42
We showed a more rapid progression of VF loss
in POAG patients with myopia > −6 D. In these
patients, closer follow-up and a lower target IOP
may be required to maintain useful vision for the
remainder of their lives.
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